IGF2 and esophageal squamous cell carcinoma: In the context of acquired resistance, it has been shown that the c-Jun/Axl axis and an upregulation of insulin growth factor 2 (IGF2) are associated with a poor response to PI3Kα blockage in HNSCC and esophageal squamous cell carcinoma cells [33–35].